The medical paradigm has shifted from treatment to prevention and management. In line with this, hospitals, which have primarily provided medical services until now, have newly positioned themselves as key players in research and development for disease prevention and management. Major advanced countries such as the United States and the United Kingdom are already jointly implementing policy initiatives to strengthen the research roles of governments and hospitals.
To promote research and development and technology commercialization in the biohealth sector, the South Korean government introduced the Research-driven Hospital initiative in 2013. In 2024, the law was revised to foster a research culture in hospitals, transitioning from a designation system to a certification system applied to hospitals with proven research capabilities, announcing 21 Research-driven Hospitals. This article covers the selection process and future directions of Research-driven Hospitals.
■Table of Contents
① Leading the Global Medical Industry… Research-driven Hospitals Are the Answer
② Korea University Anam Hospital
③ Korea University Guro Hospital
④ Korea University Ansan Hospital
⑤ Seoul National University Hospital
⑥ Seoul National University Bundang Hospital
⑦ Gangnam Severance Hospital
⑧ Hallym University Chuncheon Sacred Heart Hospital
⑨ Keimyung University Dongsan Hospital

Since being designated as a Research-driven Hospital in 2013, Korea University Anam Hospital has continuously strengthened its hospital-based research capabilities, leading global healthcare innovation.
In particular, in alignment with the era of the Fourth Industrial Revolution, it became the first in South Korea to develop a cloud-based Precision Healthcare Information System (P-HIS). This system standardizes patient data and serves as a platform for integrated management of various clinical information necessary for precision medicine, overcoming the limitations of existing medical information systems. Notably, it led Asia’s first cancer genomic profiling initiative, securing genomic data from 10,546 cancer patients and 10,158 cases, laying the foundation for personalized treatments and new drug development.
P-HIS is gaining attention not only in South Korea but also globally. In 2022, it achieved second place overall in the digital hospital evaluation by the Healthcare Information and Management Systems Society (HIMSS), the world’s largest medical IT conference, earning recognition for its technological prowess. As a result, numerous overseas hospitals and medical professionals are visiting to benchmark P-HIS.
Korea University Anam Hospital is also actively advancing its efforts to enhance smart hospital capabilities. It has established a collaboration system with LG Electronics to conduct Proof of Concept (PoC) for medical services utilizing private 5G technology. Open innovation involving hospitals, industry, and academia is accelerating the creation of a smart healthcare environment. Advancing research infrastructure is also a core priority.
Advancing research infrastructure is also a core priority. The hospital has established a differentiated medical R&D platform centered on four key research units: ▲Advanced Biomedical Engineering ▲ Innovative Precision Medicine ▲ Smart Healthcare ▲and Medical Data Science. This platform allows researchers to conduct rapid and efficient research across the entire cycle, from idea generation to clinical application and reinvestment.

Building on this, the hospital has collaborated with small and medium-sized enterprises to develop innovative technologies applicable to real clinical settings, including the world’s first ultra-miniature robotic endoscope and medical devices for real-time brain tumor diagnosis during surgery.
Realizing social value through research is also a key goal. The hospital has opened the CAR-T Anticancer Treatment Center to provide new treatment opportunities for patients with intractable cancers and is actively conducting research to address high-risk pregnancies, childbirth, and infertility.
Operating the nation’s first WHO-registered Toxic Substance Poisoning Management Center, providing researcher-led policy consultation and resource support for pandemic response, and developing a 5G-based mobile medical platform are cited as examples of enhancing the public nature and accessibility of healthcare.
In particular, the hospital is focusing on developing telemedicine technologies to address healthcare blind spots, improving the treatment environment for vulnerable patients, and building a flexible medical system that can be utilized in disaster and emergency situations, ensuring that everyone can access high-quality healthcare.
Han Seung-boom, President of Korea University Anam Hospital, stated, “Through innovative research activities, we aim to implement treatments that provide tangible benefits to patients,” adding, “We will continue to promote public health through rapid and stable research and development, realizing the social value and global medical innovation.”